Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

323

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

March 14, 2025

Study Completion Date

March 14, 2025

Conditions
Basal Cell Carcinoma
Interventions
DRUG

sonidegib

Sonidegib 200 mg orally taken once daily (dose modifications according to the approved local country prescribing information are permitted)

Trial Locations (47)

1307

Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden, Dresden

8035

Hospital Vall d'Hebron, Barcelona

8036

Hospital Clínic de Barcelona, Barcelona

8041

Hospital de la Santa Creu i Sant Pau, Barcelona

8916

Hospital Germans Trias i Pujol, Badalona

16132

Ospedale Policlinico San Martino, Genova

20133

Forndazione I.R.C.C.S. Istituto nazionale dei tumori, Milan

20246

Universitätsklinikum Hamburg-Eppendorf, Hamburg

28034

Hospital Universitario Ramón y Cajal, Madrid

28046

Hospital Universitario La Paz, Madrid

32429

Johannes Wesling Klinikum Minden, Minden

35010

Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria

36001

Complejo Hospitalario Universitario de Pontevedra, Pontevedra

38010

Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife

39120

Universitätsklinik Magdeburg, Magdeburg

46014

Hospital General Universitari València, Valencia

46026

Hospital Universitario La Fe, Valencia

46045

Helios St. Elisabeth Klinik, Oberhausen

47014

Ist. Scien. Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola

48157

Fachklinik Muenster-Hornheide, Münster

64297

Klinikum Darmstadt GmbH, Darmstadt

79104

Universitätsklinikum Freiburg, Freiburg im Breisgau

80131

Istituto Tumori Napoli Fondazione G. Pascale, Napoli

80802

Klinikum rechts der Isar, München

89081

Universitätsklinikum Ulm, Ulm

93053

Universitätsklinikum Regensburg, Regensburg

99089

Helios Klinikum, Erfurt

Unknown

Katholisches Klinikum Bochum St. Josef-Hospital, Bochum

Elbe Kliniken Stade - Buxtehude GmbH, Buxtehude

Universitaetsklinikum Essen, Essen

Universitaets-Hautklinik Kiel, Kiel

Klinikum Ludwigshafen gGmbH, Ludwigshafen

Universitaetsklinikum Schleswig-Holstein, Lübeck

Universitaetsklinikum Tuebingen, Tübingen

"I.R.C.C.S Istituto Tumori Giovanni Paolo II", Bari

ASST Spedali Civili di Brescia, Brescia

Azienda Toscana Centro - Università di Firenze, Florence

ASL1 Avezzano-Sulmona-L'Aquila, L’Aquila

Università Degli Studi di Napoli Federico II, Napoli

AOU Maggiore della Carità - Università del Piemonte Orientale, Novara

Inselspital, Bern

07548

SRH Wald-Klinikum, Gera

'30625

Medizinische Hochschule Hannover, Hanover

06484

Harzklinikum Dorothea Christiane Erxleben GmbH, Quedlinburg

00167

IDI, Roma

00168

Università Cattolica del Sacro Cuore, Roma

CH- 8091

Universitätsspital Zürich, Zurich

All Listed Sponsors
lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT04066504 - Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma | Biotech Hunter | Biotech Hunter